Scivanta Medical Corp. | Balance Sheet

Fiscal year is November-October. All values USD Thousands.
2011
2012
2013
2014
2015
Cash & Short Term Investments
46.20
64.30
19.90
26.10
21.70
Total Accounts Receivable
132.00
-
-
-
-
Other Current Assets
6.00
9.50
12.00
6.70
7.00
Total Current Assets
184.30
73.90
31.90
32.80
28.60
Total Assets
184.30
73.90
31.90
32.80
28.60
ST Debt & Current Portion LT Debt
180.00
130.00
304.60
617.30
694.80
Accounts Payable
250.20
305.50
215.60
-
-
Other Current Liabilities
307.40
315.70
138.00
375.10
590.60
Total Current Liabilities
737.60
751.20
658.20
992.40
1,285.40
Long-Term Debt
275.00
375.00
100.00
105.00
105.00
Other Liabilities
-
-
105.00
-
-
Total Liabilities
1,012.60
1,126.20
863.20
1,097.40
1,390.40
Common Equity (Total)
828.40
1,052.30
831.30
1,064.60
1,361.80
Total Shareholders' Equity
828.40
1,052.30
831.30
1,064.60
1,361.80
Total Equity
828.40
1,052.30
831.30
1,064.60
1,361.80
Liabilities & Shareholders' Equity
184.30
73.90
31.90
32.80
28.60

About Scivanta Medical

View Profile
Address
215 Morris Avenue
Spring Lake New Jersey 07762
United States
Employees -
Website -
Updated 07/08/2019
Scivanta Medical Corp. focuses on acquiring and developing medical technologies and products. The company has acquired the exclusive world-wide rights to develop, manufacture, and distribute certain proprietary technologies known as the Scivanta Cardiac Monitoring System, a minimally invasive two-balloon esophageal catheter system used to monitor cardiac performance. Scivanta Medical was founded on November 29, 1982 and is headquartered in Spring Lake, NJ.